Anti-Tuberculosis Drug Resistance in the World - Fourth Global Report
The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance
- World Health Organization (WHO)
Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.
This fourth global report is based on information collected between 2002 and 2006 on 90,000 TB patients in 81 countries. It also found that extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of the respiratory disease, has been recorded in 45 countries.
The primary aim of this report is to share survey and surveillance data on drug resistance in TB. The data presented here are supplied largely by the programme managers who have led the work on surveys, but also heads of reference laboratories as well as principle investigators that may have been hired to assist the national tuberculosis programme with the study.
The most authoritative and comprehensive resource on TB based on data from over 90,000 TB patients in 81 countries
New findings regarding drug-resistant strands of TB
Expert analysis and commentary.
|Format||Paperback||Published||04 Jun 2009|
|Availability||Available to order: 2 – 3 weeks||Delivery||Delivery options and charges|